lenvatinib Mesylate
|
- $29 - $800
- Product name: lenvatinib Mesylate
- CAS: 857890-39-2
- MF: C22H23ClN4O7S
- MW: 522.95862
- EINECS:812-398-0
- MDL Number:MFCD18633219
- Synonyms:lenvatinib Methanesulfonate;E7080 Mesylate;4-[3chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate;lenvatinib Mesylate;CAT#A863437;Lenvatinib Mesylate,Amadis Chemical offer CAS#857890-39-2;E7080;E-7080;E 7080;maltitol E:candyli(at)speedgainpharma(dot)com
22 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- AvaChem
- Biosynth Carbosynth
- Cayman Chemical
- Chemenu
- ChemScene
- Crysdot
- DC Chemicals
- Sigma-Aldrich
Package
- 5MG
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 5g
- 10g
- ManufacturerAK Scientific
- Product number0004AP
- Product descriptionLenvatinibMesilate
- Packaging250mg
- Price$131
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberKIN0001517
- Product descriptionE-7080 METHYLSULFONATE 95.00%
- Packaging5MG
- Price$505.41
- Updated2021-12-16
- Buy
- ManufacturerAvaChem
- Product number3379
- Product descriptionLenvatinib Mesylate
- Packaging5mg
- Price$29
- Updated2021-12-16
- Buy
- ManufacturerAvaChem
- Product number3379
- Product descriptionLenvatinib Mesylate
- Packaging25mg
- Price$49
- Updated2021-12-16
- Buy
- ManufacturerAvaChem
- Product number3379
- Product descriptionLenvatinib Mesylate
- Packaging100mg
- Price$79
- Updated2021-12-16
- Buy
- ManufacturerAvaChem
- Product number3379
- Product descriptionLenvatinib Mesylate
- Packaging1g
- Price$149
- Updated2021-12-16
- Buy
- ManufacturerAvaChem
- Product number3379
- Product descriptionLenvatinib Mesylate
- Packaging10g
- Price$749
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberBL166696
- Product descriptionLenvatinib mesylate
- Packaging10mg
- Price$76
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberBL166696
- Product descriptionLenvatinib mesylate
- Packaging50mg
- Price$162
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number29832
- Product descriptionLenvatinib (mesylate)
- Packaging500mg
- Price$86
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number29832
- Product descriptionLenvatinib (mesylate)
- Packaging1g
- Price$135
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number29832
- Product descriptionLenvatinib (mesylate)
- Packaging5g
- Price$421
- Updated2024-03-01
- Buy
- ManufacturerChemenu
- Product numberCM144679
- Product description4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamidemethanesulfonate 97%
- Packaging1g
- Price$153
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM144679
- Product description4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamidemethanesulfonate 97%
- Packaging5g
- Price$421
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-0030963
- Product descriptionLenvatinib(mesylate) 98.54%
- Packaging10mg
- Price$70
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-0030963
- Product descriptionLenvatinib(mesylate) 98.54%
- Packaging50mg
- Price$150
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 0004AP | LenvatinibMesilate | 250mg | $131 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | KIN0001517 | E-7080 METHYLSULFONATE 95.00% | 5MG | $505.41 | 2021-12-16 | Buy |
| AvaChem | 3379 | Lenvatinib Mesylate | 5mg | $29 | 2021-12-16 | Buy |
| AvaChem | 3379 | Lenvatinib Mesylate | 25mg | $49 | 2021-12-16 | Buy |
| AvaChem | 3379 | Lenvatinib Mesylate | 100mg | $79 | 2021-12-16 | Buy |
| AvaChem | 3379 | Lenvatinib Mesylate | 1g | $149 | 2021-12-16 | Buy |
| AvaChem | 3379 | Lenvatinib Mesylate | 10g | $749 | 2021-12-16 | Buy |
| Biosynth Carbosynth | BL166696 | Lenvatinib mesylate | 10mg | $76 | 2021-12-16 | Buy |
| Biosynth Carbosynth | BL166696 | Lenvatinib mesylate | 50mg | $162 | 2021-12-16 | Buy |
| Cayman Chemical | 29832 | Lenvatinib (mesylate) | 500mg | $86 | 2024-03-01 | Buy |
| Cayman Chemical | 29832 | Lenvatinib (mesylate) | 1g | $135 | 2024-03-01 | Buy |
| Cayman Chemical | 29832 | Lenvatinib (mesylate) | 5g | $421 | 2024-03-01 | Buy |
| Chemenu | CM144679 | 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamidemethanesulfonate 97% | 1g | $153 | 2021-12-16 | Buy |
| Chemenu | CM144679 | 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamidemethanesulfonate 97% | 5g | $421 | 2021-12-16 | Buy |
| ChemScene | CS-0030963 | Lenvatinib(mesylate) 98.54% | 10mg | $70 | 2021-12-16 | Buy |
| ChemScene | CS-0030963 | Lenvatinib(mesylate) 98.54% | 50mg | $150 | 2021-12-16 | Buy |
Properties
Melting point :>220°C (dec.)
storage temp. :-20°C Freezer
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :White to Off-White
InChIKey :HWLFIUUAYLEFCT-UHFFFAOYSA-N
SMILES :O=C(N)C1C=C2C(N=CC=C2OC2C=C(Cl)C(NC(=O)NC3CC3)=CC=2)=CC=1OC.CS(=O)(O)=O
storage temp. :-20°C Freezer
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :White to Off-White
InChIKey :HWLFIUUAYLEFCT-UHFFFAOYSA-N
SMILES :O=C(N)C1C=C2C(N=CC=C2OC2C=C(Cl)C(NC(=O)NC3CC3)=CC=2)=CC=1OC.CS(=O)(O)=O
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
Lenvatinib mesylate (lenvatinib) is an oral targeted therapy medicine known as a receptor‐type tyrosine kinase inhibitor. It is a small-molecule drug (a drug that can enter cells easily), which was developed at Eisai in 2015. It was approved by the FDA in 2015 for the treatment of differentiated thyroid cancer that is either locally recurrent, metastatic, or progressive and did not respond to radioactive iodine treatment. In May 2016, the FDA approved the drug as a combination therapy with everolimus for the treatment of advanced renal cell carcinoma. Because VEGF (and fibroblast growth factor receptors, known as FGFRs) are thought to play a role in cardiovascular signaling pathways, VEGF2R and FGFR inhibition are thought to be the mechanisms behind the primary side effect of lenvatinib mesylate, which is hypertension.More related product prices
Lenvatinib 4-chloro-7-Methoxyquinoline-6-carboxaMide 4-Amino-3-chlorophenol Methyl 4-chloro-7-Methoxyquinoline-6-carboxylate Methyl 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate 52671-64-4 Olaparib Nintedanib Ethanesulfonate Salt 918504-65-1 PLERIXAFOR Afatinib (BIBW 2992) Crizotinib Dacomitinib (PF299804)Related product price
- Lenvatinib
$5-1410 - 4-chloro-7-Methoxyquinoline-6-carboxaMide
$8-882 - 4-Amino-3-chlorophenol
$39-1549.6
Suppliers and manufacturers
Beijing Mesochem Technology Co.,Ltd
Shandong Risen-Sun Pharmaceutical Co., Ltd
